No evidence of excessive cancer screening in female noncarriers from <i>BRCA1/2</i> mutation-positive families.

Guedaoura, S; Pelletier, S; Foulkes, W D; Hamet, P; Simard, J; Wong, N; El Haffaf, Z; Chiquette, J; Dorval, M

No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation-positive families.

Guedaoura, S; Pelletier, S; Foulkes, W D; Hamet, P; Simard, J; Wong, N; El Haffaf, Z; Chiquette, J; Dorval, M.

Afiliação

Guedaoura S; Faculté de pharmacie, Université Laval, Québec.
Pelletier S; Centre de recherche du chu de Québec-Université Laval, Québec.
Foulkes WD; Centre de recherche du chu de Québec-Université Laval, Québec.
Hamet P; Departments of Human Genetics and Oncology, McGill University, Montreal.
Simard J; Sir Mortimer B. Davis Jewish General Hospital, Montreal.
Wong N; Faculté de médecine, Université de Montréal, Montréal.
El Haffaf Z; Service de médecine génique, chum, Montréal.
Chiquette J; Centre de recherche du chu de Québec-Université Laval, Québec.
Dorval M; Faculté de médecine, Université Laval, Québec; and.

Curr Oncol ; 24(6): 352-359, 2017 Dec.

Article em En | MEDLINE | ID: mdl-29270046

Palavras-chave

BRCA genes; cancer screening practices; cohort studies; familial cancer history; true noncarriers

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Curr Oncol Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google